91 related articles for article (PubMed ID: 9624868)
1. Troglitazone: a new drug for type 2 diabetes mellitus.
Deb P; Bhatia E
Natl Med J India; 1998; 11(2):81-2. PubMed ID: 9624868
[No Abstract] [Full Text] [Related]
2. Troglitazone.
Santiago JV
Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
[No Abstract] [Full Text] [Related]
3. Beneficial hepatic effect of troglitazone in a patient with antimitochondrial antibody-negative primary biliary cirrhosis.
Okai T; Mouri H; Yamaguchi Y; Nakanuma Y; Sawabu N
Am J Gastroenterol; 2002 Jan; 97(1):209-10. PubMed ID: 11808957
[No Abstract] [Full Text] [Related]
4. [Thiazolidindiones in type II diabetes mellitus].
Bornkessel B
Med Monatsschr Pharm; 1998 Mar; 21(3):66-8. PubMed ID: 9556974
[No Abstract] [Full Text] [Related]
5. Ways of changing sensitivity to insulin.
Indian J Med Sci; 1997 Dec; 51(12):481. PubMed ID: 9715548
[No Abstract] [Full Text] [Related]
6. Troglitazone, an insulin action enhancer, improves glycaemic control and insulin sensitivity in elderly type 2 diabetic patients.
Kumar S; Prange A; Schulze J; Lettis S; Barnett AH
Diabet Med; 1998 Sep; 15(9):772-9. PubMed ID: 9737807
[TBL] [Abstract][Full Text] [Related]
7. The thiazolidinediones or "glitazones" a treatment option for type 2 diabetes mellitus.
Brown MN
Med Health R I; 2000 Apr; 83(4):118-20. PubMed ID: 10821014
[TBL] [Abstract][Full Text] [Related]
8. A treatment for Mr WP: thiazolidinediones after troglitazone.
Montague CT
Diabet Med; 2002; 19 Suppl 1():7-9. PubMed ID: 11871423
[No Abstract] [Full Text] [Related]
9. Severe but reversible hepatitis induced by troglitazone.
Schiano T; Dolehide K; Hart J; Baker AL
Dig Dis Sci; 2000 May; 45(5):1039-42. PubMed ID: 10795774
[No Abstract] [Full Text] [Related]
10. Troglitazone: monotherapy indication.
Lisi DM
Arch Intern Med; 1998 Feb; 158(4):412. PubMed ID: 9487241
[No Abstract] [Full Text] [Related]
11. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
Westerbacka J; Yki-Järvinen H
Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
[No Abstract] [Full Text] [Related]
12. [Combination therapy of insulin sensitizer and sulfonylurea].
Hari J
Nihon Rinsho; 1997 Nov; 55 Suppl():197-203. PubMed ID: 9434467
[No Abstract] [Full Text] [Related]
13. [Primary prevention of diabetes mellitus by pharmacological intervention].
Noda M
Nihon Rinsho; 2002 Sep; 60 Suppl 9():100-8. PubMed ID: 12386980
[No Abstract] [Full Text] [Related]
14. [Alpha-glucosidase inhibitor and insulin sensitizer combination therapy in NIDDM].
Kitaoka H
Nihon Rinsho; 1997 Nov; 55 Suppl():192-6. PubMed ID: 9434466
[No Abstract] [Full Text] [Related]
15. [Tackling insulin resistance. Control of etiology in type 2 diabetes].
MMW Fortschr Med; 2000 May; 142(21):66-7. PubMed ID: 10872300
[No Abstract] [Full Text] [Related]
16. A potential solution for the shortage of donors in islet transplantation using a novel oral antidiabetic agent, troglitazone.
Nagai T; Yasunami Y; Nagata N; Ryu S; Ono J; Ikeda S
Transplant Proc; 1995 Dec; 27(6):3405. PubMed ID: 8540020
[No Abstract] [Full Text] [Related]
17. Rezulin (troglitazone) greatly increases cyclosporine metabolism.
Frantz RP; Nguyen TT
J Heart Lung Transplant; 1998 Oct; 17(10):1037-8. PubMed ID: 9811416
[No Abstract] [Full Text] [Related]
18. [Thiazolidinediones--new antidiabetic agents. Why don't we know how to use them?].
Gale EA
Ugeskr Laeger; 2001 Dec; 163(50):7032-5. PubMed ID: 11794032
[No Abstract] [Full Text] [Related]
19. Combination agents for diabetes.
Samuel J; Rochester CD
Adv Nurse Pract; 2003 Jun; 11(6):22-4. PubMed ID: 12807051
[No Abstract] [Full Text] [Related]
20. [30-year-old diabetic patients mostly have type 2 diabetes. "Mature" diabetics are becoming increasingly younger].
MMW Fortschr Med; 2001 Jan; 143(4):46. PubMed ID: 11219286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
